The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...

She already knew plenty about pancreatic cancer. A friend had died of it after years of treatment. Her daughter-in-law works in pancreatic cancer research. The five-year survival rate for the ...

Pancreatic cancer is one of the deadliest and most difficult-to-detect forms of cancer. It kills nearly half a million people annually and has a five-year survival rate of less than 15 percent. The ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Obesity and stress may significantly increase the risk of developing one of the most aggressive types of cancer.

Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet may work together to fuel the early ...

CA 19-9, the only Food and Drug Administration ... patients with PDAC from healthy individuals and those with noncancer pancreatic disease. They identified a matrix metalloproteinase-2 (MMP2 ...

When used alongside the existing CA 19-9 test, it was able to diagnose early-stage pancreatic cancer with 85% accuracy. Researchers pointed out that the test only uses a small amount of blood and ...